26 May 2013
Keywords: nitazoxanide, plus, soc, achieves, svr24, privately-held, drug
Article | 05 May 2008
Privately-held US drug developer Romark Laboratories says that data on its drug candidate nitazoxanide, presented at the 43rd annual meeting ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
24 May 2013
© 2013 thepharmaletter.com